Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Sheba Medical Center |
---|---|
Information provided by: | Sheba Medical Center |
ClinicalTrials.gov Identifier: | NCT00708838 |
The examination of the percentage of peripheral T cells carrying VLA-1 in ischemic heart disease patients. The hypothesis is that the percentage levels of cells carrying this integrin rise according to the severity of the ischemic heart disease.
Condition |
---|
Ischemic Heart Disease |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | VLA-1 Receptors on Peripheral T Cells in Ischemic Heart Disease Patients |
Blood samples isolated from patients included in the study and anallysed by FACS
Enrollment: | 151 |
Study Start Date: | January 2002 |
Study Completion Date: | February 2007 |
Primary Completion Date: | January 2006 (Final data collection date for primary outcome measure) |
Groups/Cohorts |
---|
1 |
2 |
3 |
4 |
5 |
Atherosclerosis is considered an inflammatory disease in which lymphocytes have an important role. The study was disigned to find out the changes in T cell levels carrying VLA-1 involvement in this process.
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Sheba Medical Center, Heart Institute ( Arik Asman ) |
Study ID Numbers: | SHEBA-02-2707-AA-CTIL |
Study First Received: | July 1, 2008 |
Last Updated: | July 1, 2008 |
ClinicalTrials.gov Identifier: | NCT00708838 |
Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
Heart Diseases Myocardial Ischemia Vascular Diseases Ischemia |
Cardiovascular Diseases |